Early Detection at Dana-Farber Helps Patient Avoid Unnecessary Treatment 

In February 2024, while being treated for pneumonia, doctors noticed that Rebecca Santorelli’s spleen was enlarged.  “No one was concerned at first,” recalls Santorelli, 61, who lives outside of Albany, New York.   Doctors estimate spleen size with fingerbreadths — or approximate widths of a finger — below the rib cage, with normal being about zero. … Read more

What is the Difference Between Gene Therapy and Immunotherapy?

Gene therapy and immunotherapy are both types of treatment for cancer and other diseases. They represent different approaches to disease therapy, though there is some overlap.  What is gene therapy?  Gene therapy is a way of treating or preventing disease by altering the genetic instructions within an individual’s cells. Most diseases aren’t caused by a … Read more

CAR T-Cell Therapy Delivers a Revelatory Experience for Myeloma Patient 

Linda Lane was still fatigued months after having COVID-19 in January of 2021.   “I told my doctor that I had not been this tired since I had a newborn in the house,” says Lane, now 57 and living on Cape Cod. “That got her attention.”  Her bloodwork came back with abnormal results. By May, the … Read more

Stem Cell Transplant Recipient Forms Powerful Bond with Doctor and Donor  

“The world needs more Dr. Soiffers – and more Nicoles.”  Such is the wisdom of Judy Mangione, 80, who credits these two individuals for the fulfilling life she is enjoying with her husband, Bob, and their combined six children and 10 grandchildren.  Robert Soiffer, MD, treated Mangione with the January 2022 stem cell transplant that … Read more

Dana-Farber Researchers Find Less Treatment May be More in Mantle Cell Lymphoma 

For a long time, the standard treatment for younger patients with newly diagnosed mantle cell lymphoma involved intensive chemotherapy, called induction therapy, followed by autologous stem cell transplant (ASCT, where the patient’s own stem cells are used), followed by maintenance therapy to help keep the cancer from coming back.   Based on recent clinical research involving … Read more

Years of Research Help Forge a New Path in Hodgkin Lymphoma Treatment  

Medical advances tend to unfold slowly over many years, fueled by successive clinical studies that build upon each other and together provide the evidence needed to change patient care. A key illustration of this point comes from a recent phase 3 clinical trial, published last October in the New England Journal of Medicine (NEJM), which … Read more

What is a Menin Inhibitor?

Menin, a protein located in the nucleus of various human cell types, often functions as a tumor suppressor by inhibiting excessive cell growth and division. If a mutation in the menin gene causes the protein to be defective or absent, uncontrolled cell growth begins — cell growth that could lay the foundations for cancer.  Dana-Farber research has also found that menin in its normal form has … Read more

Breast Cancer Survivor Provides Textured Wig Options to Women of Color 

In the midst of a lumpectomy, chemotherapy, and radiation for ​​breast cancer, Dianne Austin thought finding a wig to cover her balding head would be easy. She quickly learned otherwise.  As a Black woman, Austin desired a wig that resembled her tightly coiled, kinky and curly hair. This was 2015, and although several hospitals near … Read more

Artist Explores the Renewal and Healing of Stem Cell Transplants 

In 2023, Denise “Necee” Regis was brought face to face with her old art studio building on Brookline Avenue. As she walked by, she was able to identify the window that belonged to the room where she once spent the late 70s and early 80s working on a Master of Fine Arts at the Massachusetts … Read more

Dana-Farber Researchers Share Latest Blood Cancer and Blood Disorder Research

Dana-Farber physician-scientists presented results of more than 100 research studies at the 66th American Society of Hematology (ASH) annual meeting. Scientists shared findings across a range of hematologic disorders, underscoring the Institute’s dedication to innovation in hematologic oncology research, advances in early disease detection and intervention, and improving patient outcomes.   ASH is the world’s most comprehensive hematology … Read more

Clinical Trials in AML Seek to Eliminate ‘Leftover’ Cells That Persist After Treatment

Over the last decade, significant strides have been made in understanding the molecular underpinnings of acute myelogenous leukemia (AML) in adults, which has led to better drugs and better treatment outcomes for patients. This shifting landscape now makes it possible for cancer researchers and providers to ask, “How can we do better?” Dana-Farber medical oncologist … Read more

For Neurodiverse Patient, New Program Provides Comfort, Allies 

Naomi Dogan, PhD, still remembers a visit to the hospital earlier this year for blood work, after joining a clinical trial for patients incurring symptoms related to polycythemia vera — one of a group of rare blood disorders known as myeloproliferative neoplasms (MPNs).   In a far corner of the large room a machine quietly hummed … Read more

Living with Multiple Myeloma, Doctor Becomes Powerful Resource and Patient Advocate 

Jim Omel, MD, helped many cancer patients during his long career as a family physician, and that has not changed since his own 1997 diagnosis with multiple myeloma. What has changed is the reach of his support.  While Omel, 77, cared for primarily farming families near his Nebraska clinic during 25-plus years in practice, his … Read more

Bringing Advanced Medicines for Multiple Myeloma into Reach for All 

Multiple myeloma is a cancer of the bone marrow. It affects plasma cells, which are mature forms of blood cells called B-lymphocytes. In the case of multiple myeloma, abnormal plasma cells build up in the bone marrow, and can cause anemia. In addition, multiple myeloma may cause kidney problems, bone injury and fractures.   There have … Read more

Are There Cancers of Red Blood Cells and Blood Platelets? 

While hematological cancers like leukemia, lymphoma, and multiple myeloma involve white blood cells, other, rarer hematologic malignancies affect red blood cells and platelets. These include polycythemia vera, in which the bone marrow produces too many red blood cells, and essential thrombocythemia, in which platelets levels are abnormally high. Both are chronic diseases that can usually … Read more